165 related articles for article (PubMed ID: 3940654)
1. Neopterin as a prognostic indicator in patients with carcinoma of the uterine cervix.
Reibnegger GJ; Bichler AH; Dapunt O; Fuchs DN; Fuith LC; Hausen A; Hetzel HM; Lutz H; Werner ER; Wachter H
Cancer Res; 1986 Feb; 46(2):950-5. PubMed ID: 3940654
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of neopterin for prognosis and follow-up in ovarian cancer.
Reibnegger G; Hetzel H; Fuchs D; Fuith LC; Hausen A; Werner ER; Wachter H
Cancer Res; 1987 Sep; 47(18):4977-81. PubMed ID: 3621185
[TBL] [Abstract][Full Text] [Related]
3. Preactivated T cells in cancer patients with poor prognosis.
Fuchs DN; Fuith LC; Hausen A; Hetzel H; Reibnegger GJ; Werner ER; Wachter H
Cancer Detect Prev; 1988; 12(1-6):97-103. PubMed ID: 3141055
[TBL] [Abstract][Full Text] [Related]
4. Neopterin, a biochemical indicator of cellular immune reactions, in the detection and control of patients with neoplastic diseases.
Hausen A; Bichler A; Fuchs D; Hetzel H; Reibnegger G; Wachter H
Cancer Detect Prev; 1985; 8(1-2):121-8. PubMed ID: 4064032
[TBL] [Abstract][Full Text] [Related]
5. Neopterin and prognosis in patients with adenocarcinoma of the colon.
Weiss G; Kronberger P; Conrad F; Bodner E; Wachter H; Reibnegger G
Cancer Res; 1993 Jan; 53(2):260-5. PubMed ID: 8417818
[TBL] [Abstract][Full Text] [Related]
6. Neopterin as a marker for activated cell-mediated immunity: application in malignant disease.
Reibnegger G; Fuchs D; Fuith LC; Hausen A; Werner ER; Werner-Felmayer G; Wachter H
Cancer Detect Prev; 1991; 15(6):483-90. PubMed ID: 1782638
[TBL] [Abstract][Full Text] [Related]
7. Neopterin as discriminating and prognostic parameter in healthy homosexuals, ARC and AIDS patients.
Hutterer J; Fuchs D; Eder G; Hausen A; Knapp W; Köller U; Reibnegger G; Werner ER; Wachter H; Stingl G
Wien Klin Wochenschr; 1987 Aug; 99(15):531-5. PubMed ID: 2958970
[TBL] [Abstract][Full Text] [Related]
8. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
Kim YB; Kim GE; Pyo HR; Cho NH; Keum KC; Lee CG; Seong J; Suh CO; Park TK
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):822-9. PubMed ID: 15465199
[TBL] [Abstract][Full Text] [Related]
9. The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases.
Fuchs D; Weiss G; Reibnegger G; Wachter H
Crit Rev Clin Lab Sci; 1992; 29(3-4):307-41. PubMed ID: 1489521
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of TPA versus SCC-Ag, CEA and neopterin in carcinoma of the uterine cervix.
Volgger B; Aspisirengil C; Genser-Krimbacher E; Ciresa-Koenig A; Daxenbichler G; Fuchs D; Windbichler G; Marth C
Cancer Lett; 2008 Apr; 262(2):183-9. PubMed ID: 18226853
[TBL] [Abstract][Full Text] [Related]
11. Cervical intraepithelial neoplasia is not associated with elevated serum neopterin levels.
Strickler HD; Escoffery C; Rattray C; Fuchs D; Wachter H; Manns A; Schiffman MH; Cranston B; Hanchard B; Blattner WA
Cancer Epidemiol Biomarkers Prev; 1995; 4(3):295-8. PubMed ID: 7606206
[TBL] [Abstract][Full Text] [Related]
12. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
[TBL] [Abstract][Full Text] [Related]
13. Serum neopterin levels in haematological malignancies.
Caenazzo A; Pietrogrande F; Sgarabotto D; Dazzi F; Sartori D; Vattamattathil KP; Girolami A
Haematologica; 1993; 78(4):225-9. PubMed ID: 8294054
[TBL] [Abstract][Full Text] [Related]
14. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K
Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659
[TBL] [Abstract][Full Text] [Related]
15. [Urinary excretion of neopterin and plasma levels of interferon gamma in patients with multiple myeloma].
Spicka I; Tomsová Z; Masek Z; Procházka B; Zounar R; Klener P
Vnitr Lek; 1996 Oct; 42(10):665-8. PubMed ID: 8975455
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of interleukin-6 and neopterin in patients with multiple myeloma.
Reibnegger G; Krainer M; Herold M; Ludwig H; Wachter H; Huber H
Cancer Res; 1991 Dec; 51(23 Pt 1):6250-3. PubMed ID: 1933885
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the prognostic significance of nm23/NDP kinase protein expression in cervical carcinoma: an immunohistochemical study.
Kristensen GB; Holm R; Abeler VM; Tropé CG
Gynecol Oncol; 1996 Jun; 61(3):378-83. PubMed ID: 8641619
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341
[TBL] [Abstract][Full Text] [Related]
19. [Comment on the article "Immunologic aspects of invasive squamous cell carcinoma of the cervix uteri"].
Fuith LC; Hetzel H; Reibnegger G; Wachter H; Dapunt O
Geburtshilfe Frauenheilkd; 1988 Jun; 48(6):466-7. PubMed ID: 3262073
[No Abstract] [Full Text] [Related]
20. [Prognostic analysis of 151 patients with maxillary sinus malignant neoplasms].
Guo GF; Yang AK; Xie RH; Chen ZH; Wu QL; Ou SM; Liu WW; Xia LP; Chen MY; Zhang JX; Wu JH
Ai Zheng; 2004 Nov; 23(11 Suppl):1546-50. PubMed ID: 15566677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
